Clinical Trials Sponsored by National Institute of Allergy and infectious Diseases (NIAID)/Vaccine Research Center (VRC)

Total 986 results

National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Terminated

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

HIV Infections

United States, Peru
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

HIV Infections

United States, South Africa
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials

HIV Infections

United States, South Africa, Peru, Brazil
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Suspended

Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants (HVTN143)

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

HIV Infections

United States
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants (HVTN 135)

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
International AIDS Vaccine Initiative

Withdrawn

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

HIV Infections
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...
Novartis Vaccines; HIV Vaccine Trials Network; IPPOX Foundation

Completed

Safety and Immune Response to a Clade C DNA HIV Vaccine (HVTN111)

HIV Infections

South Africa, Zambia, Tanzania
National Institute of Allergy and Infectious Diseases...
Asthma and Allergic Diseases Cooperative Research Centers

Completed

Study of Milk Allergy and Tolerance in Children

Milk Hypersensitivity | Food Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Asthma and Allergic Diseases Cooperative Research Centers

Terminated

Human Rhinovirus Infection and Airway Remodeling Mediators

Asthma

Canada
National Institute of Allergy and Infectious Diseases...
Center for HIV/AIDS Vaccine Immunology

Completed

Examining Factors That May Influence Resistance to HIV-1 Infection

HIV Infections

Uganda, United Kingdom
Janssen Vaccines & Prevention B.V.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults

Healthy

United States
National Institute of Allergy and Infectious Diseases...
Novartis Vaccines and Diagnostics, Inc

Completed

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

HIV Infections

United States
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
National Institute of Allergy and Infectious Diseases...
Infectious Diseases Clinical Research Consortium

Recruiting

A Study of Doxycycline to Treat Chlamydial Infection

Chlamydial Infection

United States, Kenya
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Centers for Disease Control and Prevention and other collaborators

Recruiting

Anti-malaria MAb in Kenyan Children

Malaria | Plasmodium Falciparum Infection

Kenya
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis and Vaccinia Network

Completed

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Atopic Dermatitis

United States
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis and Vaccinia Network

Completed

Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

Atopic Dermatitis | Eczema Herpeticum

Germany
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

An Observational Study of Childhood Food Allergy

Milk Hypersensitivity | Egg Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity

United States
Children's National Research Institute
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Near Infrared Spectroscopy in Sickle Cell Pediatric Patients

Sickle Cell Disease

United States
Children's National Research Institute
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Pediatric COVID Outcomes Study (PECOS)

Covid19 | SARS-CoV2 Infection | MIS-C Associated With COVID-19 | MIS-C Multisystem Inflammatory Syndrome in Children

United States
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); Biofabri, S.L

Recruiting

Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa (HVTN605A5421)

Tuberculosis | HIV I Infection

South Africa
AlphaVax, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); HIV Vaccine...

Completed

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

HIV Infections

United States, Botswana, South Africa
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); EuroVacc Foundation

Completed

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

HIV Infections

Switzerland
AlphaVax, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); HIV Vaccine...

Completed

Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa

HIV Infections

United States, South Africa
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Terminated

Impact of Vaccination on Th2 Immunity in Infancy

Food Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Oral Immunotherapy for Childhood Egg Allergy

Hypersensitivity | Food Hypersensitivity | Immediate Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Psoriasis | Atopic Dermatitis

United States
Boston Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

Hepatitis C | HIV

United States
National Institute of Allergy and Infectious Diseases...
Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaborators

Withdrawn

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

HIV Infections
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

Classic Kaposi Sarcoma | AIDS-related Kaposi Sarcoma
National Cancer Institute (NCI)

Completed

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Centers for Disease Control and Prevention

Completed

Rapid HIV Testing for Emergency Department Patients

HIV Infections

United States
M.D. Anderson Cancer Center
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome

Bronchiolitis Obliterans

United States
Fred Hutchinson Cancer Center
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

Systemic Scleroderma | Severe Systemic Sclerosis

United States
National Institute of Allergy and Infectious Diseases...
Auro Vaccines LLC

Completed

Therapeutic Vaccine for HIV

HIV | Therapeutic Vaccine

United States
Montefiore Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD (TFPP-PLWH)

HIV | Post Traumatic Stress Disorder

United States
University of Miami
National Institute of Allergy and Infectious Diseases (NIAID); Vaccine and...

Completed

Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study

HIV

United States
National Institute of Allergy and Infectious Diseases...
National Cancer Institute (NCI)

Completed

A Study of Azidothymidine in HIV-Infected Children

HIV Infections | Encephalopathies

United States
National Institute of Allergy and Infectious Diseases...
National Cancer Institute (NCI)

Completed

A Study of Patients With AIDS Syndrome

HIV Infections | Lymphoma, Non-Hodgkin | Lymphoma, AIDS-Related | Sarcoma, Kaposi

United States
University Clinical Research Center, Mali
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Epidemiology and Clinical Characteristics of Emerging and Re-emerging Infectious Diseases With Epidemic Potential in Mali (ECERID)

Febrile Illness

Mali
Vir Biotechnology, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); HIV Vaccine...

Recruiting

To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV

HIV I Infection

United States, South Africa

Clinical Trials Sponsored by National Institute of Allergy and infectious Diseases (NIAID)/Vaccine Research Center (VRC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations